The potential deal is expected to produce $1 billion in synergies. As per a Wall Street Journal report, Marathon Petroleum Corp, a U.S. refiner has proposed to acquire its peer Andeavor for more than $20 billion in a cash-and-stock deal… Read More ›
M&A
Whirlpool divests its Embraco compressor business to Japan’s Nidec Corp for $1.08 billion
The strategic divestiture is aimed at increasing its focus on its consumer business. On Tuesday, Whirlpool Corp, a U.S. home appliance maker, disclosed it has agreed to divest its Embraco compressor business to Japan’s Nidec Corp for $1.08 billion. The… Read More ›
Bayer gets Russia’s nod for its $66 billion acquisition of Monsanto
Bayer has already received approval from the EU, Australia, Brazil, China; Russia now adds to this list. In a development that aids Bayer’s $66 billion acquisition of Monsanto, it has now got approval from FAS, Russia’s antitrust regulator, for its… Read More ›
Procter & Gamble Co acquires Merck KgaA’s consumer health business for $4.21 billion
Where other companies, including Nestle, Stada and Perrigo, failed, P&G succeeded. The purchase will help it expand its portfolio of consumer healthcare capabilities and brands. On Thursday, Procter & Gamble Co and Merck KgaA stated, the former has agreed to… Read More ›
Xerox-Fuji Film merger deal faces flak in amended lawsuit
The amended lawsuit has been filed by Darwin Deason, a Xerox shareholder, who along with activist shareholder Carl Icahn have nearly 15% stake in Xerox. As per a report by the Wall Street Journal, a lawsuit has been filed alleging… Read More ›
Bayer gets antitrust approval from U.S. Justice Department for its $62.5 billion acquisition of Monsanto
The combined company will control more than a quarter of the world’s seed and pesticide market. With the U.S. Justice Department giving the green signal to Bayer AG’s bid to acquire Monsanto Co for $62.5 billion deal, with both companies… Read More ›
Novartis to acquire AveXis for $8.7 billion
The acquisition will add AveXis top drug to its repertoire of drugs, which has a significant market in the U.S. for spinal muscular atrophy. On Monday, Switzerland-based healthcare giant Novartis announced its $8.7 billion deal to acquire AveXis; Novartis will… Read More ›
Walmart Inc takes the fight to Amazon.com Inc: explores close ties with health insurer, Humana Inc
If a deal was to materialize, Walmart will have to navigate the complex U.S. healthcare industry while meeting the challenges of a rapidly changing retail market. As per sources familiar with the matter at hand, Walmart Inc, the world’s… Read More ›
Akzo Nobel to sell its Specialty Chemicals business to Carlyle Group GIC for $12.6 billion
The deal may have been aimed at avoiding a takeover from its rival PPG Industries. On Tuesday, Akzo Nobel disclosed that it will be selling its Specialty Chemicals business to U.S. private equity firm Carlyle Group and Singapore’s GIC for… Read More ›
Reckitt Benckiser Group withdraws from race to acquire Pfizer Inc’s consumer healthcare business
With Reckitt Benckiser out of the race, it is advantage GlaxoSmithKline Plc. Reckitt Benckiser Group, a British consumer goods group, has withdrawn from discussions with Pfizer Inc over buying its consumer healthcare business. According to sources familiar with the matter… Read More ›
manageria.biz 